세계의 단백질 가수분해물 시장 : 기회, 성장 촉진요인, 산업 동향 분석, 예측(2025-2034년)

The Global Protein Hydrolysates Market was valued at USD 3.5 billion in 2024 and is estimated to grow at a CAGR of 4.9% to reach USD 5.7 billion by 2034. The growing demand for functional and easily digestible nutritional components across diverse sectors is fueling the expansion of this market. Protein hydrolysates are produced from sources such as plant, dairy, animal, and marine proteins, and are prized for their enhanced bioavailability and functional versatility. Their rapid absorption makes them especially valuable in sports nutrition, while the infant nutrition segment continues to grow steadily due to increasing demand for hypoallergenic and easily digestible formulas. These proteins are also widely used in areas like medical nutrition, personal care products, pharmaceutical-grade formulations, animal feeds, and pet nutrition. Among the various production techniques, enzymatic hydrolysis remains the dominant method, appreciated for its efficiency and ability to yield high-quality hydrolysates with fewer unwanted by-products.

Although chemical and microbial hydrolysis methods continue to play a role in producing customized protein hydrolysates with specific functional or nutritional attributes, they are often limited by by-product formation and less-controlled reaction environments. Physical methods such as thermal processing, while less widely adopted, are being revisited with new techniques that reduce protein degradation and improve reaction efficiency. Recent breakthroughs in biotechnology, precision fermentation, and membrane separation are now enabling manufacturers to fine-tune hydrolysate composition at a molecular level. These advances are driving the development of next-generation hydrolysates optimized for specialized sectors like medical nutrition, plant-based sports recovery, personalized supplements, and even cosmetic formulations.

The dairy-based protein hydrolysates segment generated USD 1.4 billion in 2024 and comprising 40% share. These products are primarily used in infant formulations, medical nutrition, and athletic recovery products due to their excellent absorption and functional characteristics. With their superior nutritional profile, whey and casein derivatives are central to the segment's performance. The segment's strength stems from high nutritional quality and increasing awareness around protein efficacy in various life stages.

The infant nutrition segment held 19.9% share in 2024, driven by the increasing need for protein sources that are both safe and digestible for infants with sensitivities or allergies to traditional milk proteins. The use of hydrolyzed proteins in baby formulas continues to grow due to heightened consumer focus on allergen-free and gut-friendly alternatives. This segment is shaped not only by regulatory policies but also by a stronger demand for health-conscious infant solutions from well-informed parents.

United States Protein Hydrolysates Market held 80.1% share in 2024, contributing USD 1 billion. The country has established itself as a mature and innovation-driven landscape for protein hydrolysates, supported by consumer preference for health-forward, science-backed food products. Growing trends in digestive health, muscle recovery, and immune function are further pushing development across different protein formats. Additionally, the rise in clean-label expectations and interest in plant-based alternatives is prompting producers to innovate beyond dairy-sourced proteins. Manufacturers are introducing more sustainable, bioavailable protein ingredients that align with evolving consumer values.

Key players leading the Global Protein Hydrolysates Market include Cargill, Incorporated, Davisco Foods International, Archer Daniels Midland Company, Fonterra Co-operative, and Arla Foods Ingredients. Major manufacturers are leveraging R&D investments to design hydrolysate formulations tailored to niche health functions such as immune support, gut health, and sports recovery. Strategic collaboration with clinical researchers and formulation specialists is allowing brands to enhance bioactivity and tailor peptide profiles for targeted applications. Leading players are expanding their product portfolios with dairy-free and allergen-reduced options to meet rising clean-label and plant-based trends. Additionally, companies are strengthening supply chain resilience by increasing local sourcing, improving traceability, and investing in processing innovation to ensure consistent product quality and cost-effective scalability in both developed and emerging markets.

Table of Contents

Chapter 1 Methodology

• 1.1 Market scope and definition
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Data mining sources
  • 1.3.1 Global
  • 1.3.2 Regional/Country
• 1.4 Base estimates and calculations
  • 1.4.1 Base year calculation
  • 1.4.2 Key trends for market estimation
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
• 1.6 Forecast model
• 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis, 2021 - 2034
• 2.2 Key market trends
  • 2.2.1 Regional
  • 2.2.2 Source
  • 2.2.3 Application
  • 2.2.4 Production method
  • 2.2.5 End Use
  • 2.2.6 Distribution channel
• 2.3 TAM Analysis, 2025-2034
• 2.4 CXO perspectives: Strategic imperatives
  • 2.4.1 Executive decision points
  • 2.4.2 Critical success factors
• 2.5 Future outlook and strategic recommendations

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
  • 3.1.1 Supplier landscape
  • 3.1.2 Profit margin analysis
  • 3.1.3 Cost structure
  • 3.1.4 Value addition at each stage
  • 3.1.5 Factor affecting the value chain
  • 3.1.6 Disruptions
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising demand for sports and clinical nutrition products
    • 3.2.1.2 Growing preference for plant-based and allergen-free proteins
    • 3.2.1.3 Advancements in enzymatic hydrolysis technology
    • 3.2.1.4 Increasing awareness of protein’s health benefits
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High production costs and complex processing methods
    • 3.2.2.2 Stringent regulatory requirements for food ingredients
  • 3.2.3 Market opportunities
    • 3.2.3.1 Expansion into functional foods and beverages segment
    • 3.2.3.2 Growth in nutraceuticals and personalized nutrition
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
  • 3.4.1 North America
  • 3.4.2 Europe
  • 3.4.3 Asia Pacific
  • 3.4.4 Latin America
  • 3.4.5 Middle East & Africa
• 3.5 Porter's analysis
• 3.6 PESTEL analysis
• 3.7 Technology and Innovation landscape
  • 3.7.1 Current technological trends
  • 3.7.2 Emerging technologies
• 3.8 Price trends
  • 3.8.1 By region
  • 3.8.2 By source
• 3.9 Cost breakdown analysis
• 3.10 Patent analysis
• 3.11 Sustainability and environmental aspects
  • 3.11.1 Sustainable practices
  • 3.11.2 Waste reduction strategies
  • 3.11.3 Energy efficiency in production
  • 3.11.4 Eco-friendly Initiatives
• 3.12 Carbon footprint considerations

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
  • 4.2.1 North America
  • 4.2.2 Europe
  • 4.2.3 Asia Pacific
  • 4.2.4 LATAM
  • 4.2.5 MEA
• 4.3 Competitive analysis of major market players
• 4.4 Competitive positioning matrix
• 4.5 Strategic outlook matrix
• 4.6 Key developments
  • 4.6.1 Mergers & acquisitions
  • 4.6.2 Partnerships & collaborations
  • 4.6.3 New Product Launches
  • 4.6.4 Expansion Plans and funding

Chapter 5 Market Estimates & Forecast, By Source, 2021 - 2034 (USD Bn, Units)

• 5.1 Key trends
• 5.2 Dairy
  • 5.2.1 Whey
  • 5.2.2 Casein
  • 5.2.3 Milk
• 5.3 Plant
  • 5.3.1 Soy
  • 5.3.2 Pea
  • 5.3.3 Rice
  • 5.3.4 Wheat
  • 5.3.5 Other plant sources
• 5.4 Animal
  • 5.4.1 Meat
  • 5.4.2 Collagen
  • 5.4.3 Egg
• 5.5 Marine
  • 5.5.1 Fish
  • 5.5.2 Seafood
  • 5.5.3 Marine

Chapter 6 Market Estimates & Forecast, By Application, 2021 - 2034 (USD Bn, Units)

• 6.1 Key trends
• 6.2 Food and beverages
  • 6.2.1 Functional foods
  • 6.2.2 Beverages
  • 6.2.3 Bakery and confectionery
  • 6.2.4 Dairy products and alternatives
  • 6.2.5 Meat and meat alternatives
• 6.3 Sports nutrition
  • 6.3.1 Powders and supplements
  • 6.3.2 Pre- and post-workout products
  • 6.3.3 Recovery and endurance products
  • 6.3.4 Weight management products
• 6.4 Infant nutrition
• 6.5 Clinical and medical nutrition
• 6.6 Animal feed and pet food
• 6.7 Cosmetics and personal care
• 6.8 Pharmaceuticals and nutraceuticals

Chapter 7 Market Estimates & Forecast, By Production Method, 2021 - 2034 (USD Bn, Units)

• 7.1 Key trends
• 7.2 Enzymatic
• 7.3 Chemical
• 7.4 Microbial
• 7.5 Novel and emerging methods

Chapter 8 Market Estimates & Forecast, By End Use, 2021 - 2034 (USD Bn, Units)

• 8.1 Key trends
• 8.2 B2B food and beverage manufacturers
• 8.3 Nutraceutical and supplement companies
• 8.4 Pharmaceutical companies
• 8.5 Animal feed and pet food manufacturers
• 8.6 Cosmetics and personal care companies
• 8.7 Research and academic institutions
• 8.8 Direct-to-consumer brands

Chapter 9 Market Estimates & Forecast, By Distribution Channel, 2021 - 2034 (USD Bn, Units)

• 9.1 Key trends
• 9.2 Direct sales
• 9.3 Distributors and wholesalers
• 9.4 Online B2B platforms
• 9.5 Others

Chapter 10 Market Estimates & Forecast, By Region, 2021 - 2034 (USD Bn, units)

• 10.1 Key trends
• 10.2 North America
  • 10.2.1 U.S.
  • 10.2.2 Canada
• 10.3 Europe
  • 10.3.1 UK
  • 10.3.2 France
  • 10.3.3 Italy
  • 10.3.4 Spain
• 10.4 Asia Pacific
  • 10.4.1 China
  • 10.4.2 India
  • 10.4.3 Japan
  • 10.4.4 Australia
  • 10.4.5 South Korea
  • 10.4.6 Indonesia
• 10.5 Latin America
  • 10.5.1 Brazil
  • 10.5.2 Mexico
  • 10.5.3 Argentina
• 10.6 MEA
  • 10.6.1 South Africa
  • 10.6.2 Saudi Arabia
  • 10.6.3 UAE
  • 10.6.4 Egypt

Chapter 11 Company Profiles

• 11.1 Archer Daniels Midland Company (ADM)
• 11.2 Arla Foods Ingredients
• 11.3 Cargill, Incorporated
• 11.4 Davisco Foods International
• 11.5 Fonterra Co-operative Group Limited
• 11.6 FrieslandCampina
• 11.7 Glanbia plc
• 11.8 Hilmar Ingredients
• 11.9 Ingredia SA
• 11.10 Kerry Group plc